|
|
Article: Zila's Inter-Cal Research Supports Advantages Of Ester-C(R) Mineral Ascorbate Over Plain Vitamin C.
- Article from:
- PR Newswire
- Article date:
- March 1, 1999
CopyrightCOPYRIGHT 1999 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PRESCOTT, Ariz., March 1 /PRNewswire/ -- Inter-Cal Corporation, a division of Oxycal Laboratories which is a unit of Zila, Inc. (Nasdaq: ZILA), announced results of a new clinical study further supporting the advantages of Ester-C(R) mineral ascorbate, a patented form of vitamin C. The new research corroborates and expands earlier human and cellular studies which suggested the efficacy of Ester-C ascorbates. In research conducted at the University of California/Los Angeles (UCLA), human subjects who took Ester-C mineral ascorbate maintained significantly higher levels of vitamin C in their white blood cells over a longer period of time, compared to taking comparable ...